- Advertisement -
Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of death by more than 40%.
Researchers tested a therapy that combines enzalutamide, an existing cancer drug, with standard…
